| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1827-SCLC, MRI Surveillance +/- PCI | 1 | Y | 1 PCI + MRI brain surveillance | 668 | 106 | 36 | 13 | 10 | 1 | 0 | 05/04/2020 | 326 | 128 |
| 2 MRI brain surveillance | 107 | 37 | 17 | 14 | 3 | 0 | ||||||||
| 213 | 73 | 30 | 24 | 4 | 0 | |||||||||
| S1914-NSCLC, High Risk Early Stg, SBRT +/- Atezo | 1 | Y | 1 Atezolizumab and SBRT | 480 | 178 | 77 | 44 | 26 | 6 | 0 | 08/13/2020 | 355 | 123 | |
| 2 SBRT | 172 | 73 | 36 | 17 | 4 | 0 | ||||||||
| 350 | 150 | 80 | 43 | 10 | 0 | |||||||||
| S1933-NSCLC, Stg II-III, RT + Atezo | 1 | Y | 1 Hypofractionated Radiotherapy | 47 | 36 | 8 | 6 | 3 | 1 | 0 | 01/13/2021 | 104 | 42 | |
| 36 | 8 | 6 | 3 | 1 | 0 | |||||||||
| 2 | Y | 2 Atezolizumab | 29 | 6 | 5 | 4 | 2 | 0 | 01/13/2021 | |||||
| 29 | 6 | 5 | 4 | 2 | 0 | |||||||||
| S2302-NSCLC, Stg IV or Recur, Ramu + Pembro vs SoC | 1 | Y | 1 Standard of Care (Inv. Choice) | 700 | 222 | 217 | 135 | 68 | 19 | 2 | 03/14/2023 | 440 | 180 | |
| 2 Ramucirumab + Pembrolizumab | 223 | 218 | 132 | 72 | 24 | 4 | ||||||||
| 445 | 435 | 267 | 140 | 43 | 6 | |||||||||
| Yes | A081801-ALCHEMIST4, ALK and EGFR negative, Chemo-IO | 1 | E | Total Registrations | 75 | 19 | 8 | 5 | 2 | 0 | 10/20/2020 | 405 | 172 | |
| 75 | 19 | 8 | 5 | 2 | 0 | |||||||||
| A151216-ALCHEMIST0 - screening | 1 | E | Total Registrations | 975 | 33 | 13 | 6 | 1 | 1 | 12/16/2014 | 495 | 236 | ||
| 975 | 33 | 13 | 6 | 1 | 1 | |||||||||
| E4512-ALCHEMIST2, ALK mut, Crizotinib | 1 | E | Total Registrations | 22 | 6 | 3 | 2 | 0 | 0 | 02/29/2016 | 461 | 209 | ||
| 22 | 6 | 3 | 2 | 0 | 0 | |||||||||
| EA5162-NSCLS,StgIV/IIB,EGFR exon20 insertion,AZD9291 | 1 | E | Total Registrations | 1 | 1 | 0 | 0 | 0 | 0 | 08/23/2023 | 74 | 38 | ||
| 1 | 1 | 0 | 0 | 0 | 0 | |||||||||
| EA5182-NSCLC, Met EGFR mut, AZD9291+Beva vs AZD9291 | 1 | E | Total Registrations | 14 | 7 | 4 | 3 | 0 | 0 | 04/28/2021 | 168 | 78 | ||
| 14 | 7 | 4 | 3 | 0 | 0 | |||||||||
| NRGLU008-Lung NSCL, StgII-III, StereoBodyRad/MedChemo | 1 | E | Total Registrations | 1 | 1 | 1 | 1 | 0 | 0 | 01/26/2024 | 27 | 6 | ||
| 1 | 1 | 1 | 1 | 0 | 0 | |||||||||
| No | A082002-Lung, Adv, Systemic Tx +/- SBRT | 1 | E | Total Registrations | 4 | 1 | 1 | 0 | 0 | 0 | 10/12/2022 | 172 | 61 | |
| 4 | 1 | 1 | 0 | 0 | 0 | |||||||||
| A151216-ALCHEMIST0 - screening | 0 | E | Total Registrations | 989 | 35 | 13 | 6 | 1 | 1 | 12/16/2014 | 495 | 236 | ||
| 989 | 35 | 13 | 6 | 1 | 1 | |||||||||